Manning Institute of Biotechnology ??? Construction Phase Services and Enabling Site…

Skanska USA Building Inc. has been awarded a Construction Manager at Risk contract by the University of Virginia for the Manning Institute of Biotechnology project. The contract, designated A207_PO-0158614-V17, was executed on September 3, 2026, and carries a cumulative value of $50,937,044.90. The scope of work encompasses both design phase services and construction phase services, along with enabling site package activities. The project is identified under Project Code 207-B1303-001, Work Order #3397361, and Project #PJ02847.

Under this engagement, Skanska USA Building Inc. will serve as Construction Manager at Risk, providing comprehensive project delivery services for the biotechnology institute's development. The contract represents a single line item deliverable valued at $50,937,044.90. While specific performance timelines and detailed site locations within Virginia are not explicitly detailed in the contract documentation, the University of Virginia serves as the contracting organization and project owner. This award reflects a substantial institutional investment in biotechnology research infrastructure development within the Commonwealth of Virginia.